Related Experiment Video
Updated: May 26, 2026

Evaluating Therapeutic and Chemical Toxicity Using Organ-Cultured Porcine Corneas and Epithelial Wound Healing
Published on: January 10, 2025
High glucose may decrease the innate immune through TLRs in cornea epithelium
Hailong Ni1, Xiaoran Yan, Zhenyun Lin
1Eye Center, Affiliated Second Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Purpose:
The purpose of this study was to investigate the high potential of glucose in inhibiting the innate immune in cultured human cornea epithelial cells (HCEC) and try to determine whether the role of high glucose on the HCEC relate to toll-like receptor (TLR)2 and TLR4.
Methods:
Cells were cultured for 3 days in 5 mmol/l (normal glucose). Then high glucose (25 mmol/l) was added along with normal glucose with daily changes in media for 24 h. The cells were also treated with mannitol as an osmotic control. The cellular abundance of the mRNAs for TLR2 and TLR4 was determined by real-time polymerase chain reaction analysis. The proteins of TLR2 and TLR4 were also compared by immunofluorescent staining and western blot. The release of interleukin 6 (IL-6) and IL-8 from cultured HCEC was measured using enzyme-linked immunosorbent assays (ELISA) in the presence and absence of specific blocking antibodies to TLR2 and TLR4.
Results:
Incubation of HCEC with high glucose showed that the mRNA expression of TLR2 and TLR4 was markedly inhibited. Immunofluorescent staining and western blot analysis confirmed that the protein expression of TLR2 and TLR4 was downregulated in response to high glucose. The result of ELISA also showed that the release of IL-6 and IL-8 can be inhibited by high glucose, but these inhibitions were partly counteracted after pretreatment with anti-TLR2 and/or anti-TLR4 monoclonal antibody. The results also showed that the osmotic control did not affect the expression of TLR2, TLR4, and IL-6, 8.
Conclusions:
High glucose may decrease the innate immune through TLRs in cornea epithelium.
Insights
High glucose inhibits innate immune responses in human cornea epithelial cells by downregulating toll-like receptor (TLR)2 and TLR4 expression. This finding suggests a novel mechanism for high glucose-induced immune modulation in the cornea.
Area of Science:
- Ophthalmology
- Immunology
- Cell Biology
Background:
- The innate immune system protects the cornea from pathogens.
- Toll-like receptors (TLRs) are key components of innate immunity.
- The effect of high glucose on corneal innate immunity is not fully understood.
Purpose of the Study:
- To investigate the inhibitory effect of high glucose on innate immunity in cultured human cornea epithelial cells (HCEC).
- To determine if high glucose affects HCEC by modulating toll-like receptor (TLR)2 and TLR4.
Main Methods:
- HCEC were cultured and exposed to normal or high glucose concentrations.
- Messenger RNA (mRNA) and protein expression of TLR2 and TLR4 were analyzed using real-time PCR, immunofluorescence, and western blot.
- Interleukin-6 (IL-6) and IL-8 release was measured via ELISA, with and without TLR2/TLR4 blocking antibodies.
Main Results:
- High glucose significantly inhibited mRNA and protein expression of TLR2 and TLR4 in HCEC.
- High glucose reduced the release of IL-6 and IL-8.
- Blocking TLR2 and TLR4 partially reversed the inhibitory effects of high glucose on cytokine release.
Conclusions:
- High glucose concentrations can suppress the innate immune response in cornea epithelial cells.
- This suppression appears to be mediated, at least in part, through the downregulation of TLR2 and TLR4.
More Related Videos
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
09:03Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation
Published on: November 17, 2014
Related Concept Videos
Glucose Absorption Into the Small Intestine
Glaucoma: Overview
Microbiome of the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology